SLIRP Regulates the Rate of Mitochondrial Protein Synthesis and Protects LRPPRC from Degradation

PLoS Genet. 2015 Aug 6;11(8):e1005423. doi: 10.1371/journal.pgen.1005423. eCollection 2015 Aug.

Abstract

We have studied the in vivo role of SLIRP in regulation of mitochondrial DNA (mtDNA) gene expression and show here that it stabilizes its interacting partner protein LRPPRC by protecting it from degradation. Although SLIRP is completely dependent on LRPPRC for its stability, reduced levels of LRPPRC persist in the absence of SLIRP in vivo. Surprisingly, Slirp knockout mice are apparently healthy and only display a minor weight loss, despite a 50-70% reduction in the steady-state levels of mtDNA-encoded mRNAs. In contrast to LRPPRC, SLIRP is dispensable for polyadenylation of mtDNA-encoded mRNAs. Instead, deep RNA sequencing (RNAseq) of mitochondrial ribosomal fractions and additional molecular analyses show that SLIRP is required for proper association of mRNAs to the mitochondrial ribosome and efficient translation. Our findings thus establish distinct functions for SLIRP and LRPPRC within the LRPPRC-SLIRP complex, with a novel role for SLIRP in mitochondrial translation. Very surprisingly, our results also demonstrate that mammalian mitochondria have a great excess of transcripts under basal physiological conditions in vivo.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cells, Cultured
  • Female
  • Gene Expression Regulation
  • Male
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mitochondrial Proteins / biosynthesis*
  • Neoplasm Proteins / metabolism*
  • Polyadenylation
  • Protein Biosynthesis
  • Proteolysis
  • RNA Stability
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • RNA-Binding Proteins / physiology*
  • Ribosomes / metabolism

Substances

  • Lrpprc protein, mouse
  • Mitochondrial Proteins
  • Neoplasm Proteins
  • RNA, Messenger
  • RNA-Binding Proteins
  • SLIRP protein, mouse

Grants and funding

The study was supported by a post-doctoral grant from the AXA Research Fund (ARF) to ML, by a European Research Council advanced investigator grant (268897) and by grants from the Deutsche Forschungsgemeinschaft (SFB829) and the Swedish Research Council (2013–2859) to NGL. AF is a National Health and Medical Research Council Senior Research Fellow (APP 1058442) and supported by an Alexander von Humboldt Fellowship for experienced researchers. Members of the GMC were funded by the German Federal Ministry of Education and Research (Infrafrontier grant 01KX1012). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.